An update on the Second Sight Medical Products (NASDAQ:EYES) saga comes to us by way of IEEE Spectrum, offering a cautionary tale for the developers of cutting-edge implants and the patients who place their faith in them. The future remains cloudy for the Los Angeles–based developer of the Argus 2s retinal prosthesis system, which is […]
Optical/Ophthalmic
Alcon stock up on Street-beating Q4
Alcon (SIX/NYSE:ALC) stock is up today after the eye care tech company reported fourth-quarter results that surpassed Wall Street expectations. Geneva, Switzerland–based Alcon yesterday evening reported profits of $139 million, or 28¢ per share, off $2.149 billion in sales for the quarter ended Dec. 31, 2021, for a bottom-line gain of 46% and a top-line […]
Minnetronix and INO team up on optical medical device development
Minnetronix Medical and INO Innovation Center today announced a strategic partnership to innovate and accelerate the development of optical medical devices. For their first completed project, INO developed a smart illumination system for an unidentified customer and Minnetronix led the system integration. The companies said in a news release that their partnership can also manage […]
Glaukos announces executive leadership changes
Glaukos this week announced several executive leadership changes that will take place on April 1. Joseph Gilliam is appointed as president and COO. He previously served as the CFO and SVP of corporate development for the San Clemente, California-based ophthalmic medtech and pharma company since 2017. Here are Glaukos’ new executive committee appointments: Chris Calcaterra […]
These medtech companies care a lot about research
They’re making glaucoma-treating stents, tumor-treating fields, coin-sized CGMs and more. Discover the medtech companies that spend the most on research as a percentage of revenue. The list comes from our annual Big 100 report, which examines the world’s 100 largest medical device companies and ranks them by revenue. (Check out our full Big 100 report […]
FDA grants breakthrough designation for WaveGate closed-loop spinal cord stimulation
Wavegate announced today that it received FDA breakthrough device designation for its StimuLux optical reflectometry system. Lake Charles, Louisiana-based Wavegate designed the StimuLux system for the closed-loop adaptive modulation of spinal cord stimulation. Breakthrough designation will expedite the development and regulatory review processes for the platform. According to a news release, StimuLux makes up part […]
Alcon closes Ivantis acquisition
Alcon (NYSE:ALC) announced today that it completed its $475 million acquisition of glaucoma surgery device maker Ivantis. Geneva, Switzerland-based Alcon initially announced the acquisition of Ivantis, which develops the Hydrus Microstent minimally invasive glaucoma surgery (MIGS) device, in November 2021. Get the full story at our sister site, Medical Tubing & Extrusion.
FDA clears Glaukos’ iPrime
Glaukos (NYSE:GKOS) announced that it received FDA 510(k) clearance for its iPrime viscodelivery system. San Clemente, California-based Glaukos designed the Prime viscodelivery system as a sterile, single-use, minimally invasive device for delivering viscoelastic fluid during ophthalmic surgery. Get the full story at our sister site, Drug Delivery Business News.
Ocular Therapeutix touts positive trial results of ophthalmic insert for dry eye disease
Ocular Therapeutix (NSDQ:OCUL) announced today that it reported positive results from a Phase 2 trial of its dry eye disease treatment. Bedford, Massachusetts-based Ocular Therapeutix’s U.S.-based Phase 2 clinical trial evaluated OTX-DED (dexamethasone intracanalicular ophthalmic insert) for the short-term treatment of dry eye disease. Get the full story at our sister site, Drug Delivery Business News.
Corza Medical acquires Katena Products
Private equity firm GTCR announced today that Corza Medical acquired Katena Products and its ophthalmic surgery offerings. Katena develops ophthalmic products used across cataract, glaucoma and corneal surgeries, including precision surgical instruments, single-use devices and specialty biologics, according to a news release. The company, which has more than 200 employees across North America and Europe, […]
FDA grants IDE nod to LensGen’s presbyopia-correcting intraocular lens
Intraocular lens developer LensGen announced today that it received FDA investigational device exemption (IDE) for its Juvene lens. Irvine, California-based LensGen designed the Juvene intraocular lens (IOL) for patients with cataracts, with the IDE set to initiate a pivotal study for the device. The company developed Juvene IOL t0 permanently restore clear and continuous vision at […]